Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for COVID-19 prevention in the elderly
NCT04417335Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Radboud University Medical Center. Primary endpoint: SARS-CoV-2 related hospital admission at 1 year. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04417335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417335.